Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2007
11/07/2007EP1613597B1 6-substituted nicotinamide derivatives as opioid receptor antagonists
11/07/2007EP1523486B1 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
11/07/2007EP1513526B1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
11/07/2007EP1401408A4 Controlled heat induced rapid delivery of pharmaceuticals from skin depot
11/07/2007EP1361225B1 Compounds substituted with bicyclic amino groups
11/07/2007EP1317276B1 Therapeutic use of a recombinant erythropoietin omega having high activity and reduced side effects
11/07/2007EP1257281B1 Nucleoside analogs with carboxamidine modified monocyclic base
11/07/2007EP1165523B1 Neurotrophic substituted pyrimidines
11/07/2007EP1144671B1 Enriched central nervous system cell populations
11/07/2007EP1042288B1 Tripeptidyl peptidase inhibitors
11/07/2007EP1017713B1 CYCLIC ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS
11/07/2007CN101068827A Polymorphs of sarsasapogenin
11/07/2007CN101068801A Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
11/07/2007CN101068798A Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine
11/07/2007CN101068788A Quinoline as allosteric enhancers of the gaba-b receptors
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101068595A Cgrp受体拮抗剂 Cgrp receptor antagonists
11/07/2007CN101068534A Pharmaceutical compositions comprising levetiracetam and process for their preparation
11/07/2007CN101066997A Human antibodies that bind human IL-12 and methods for producing
11/07/2007CN101066439A Wind dispelling and obstruction eliminating capsule and its prepn
11/07/2007CN101066412A Brain nourishing and eyesight improving tea
11/07/2007CN101066396A Externally applied for treating hemicrania
11/07/2007CN101066355A Chinese medicine prepn for treating toothache and its prepn process
11/07/2007CN101066352A Chinese medicine prepn for treating headache during menstruation
11/07/2007CN101066349A Chinese herbal medicine composition for treating dizziness
11/07/2007CN101066332A Chinese medicine composition for treating headache during menstruation
11/07/2007CN101066325A Chinese herbal medicine liniment for treating paralysis
11/07/2007CN101066291A Chinese medicine composition for transquilizing, warming Yang, benefiting Qi and nourishing heart and its prepn
11/07/2007CN101066289A Medicine for treating Qi deficiency
11/07/2007CN101066288A Medicine composition containing notoginseng leaf extract and its use
11/07/2007CN101066278A Medicine use of energy mixture
11/07/2007CN101066276A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/07/2007CN101066268A Application of compound 6-furfuryl amino purine in preparing medicine for treating brain tissue oxidizing damage
11/07/2007CN101066267A Solid oral medicine composition containing aripiprazole microcrystal
11/07/2007CN101066266A Organic salt of pyritinol and its prepn process
11/07/2007CN101066244A Small volume vincamine injection and its prepn process
11/07/2007CN101066083A Health tea of aizoon stonecrop herb
11/07/2007CN100347306C Method and means for producing protein with prospective post-translation modification
11/07/2007CN100347293C Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
11/07/2007CN100347171C Pyridine compounds and their prepn and application as Dopamine D4 receptor agonist
11/07/2007CN100347170C Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
11/07/2007CN100347169C 喹唑啉衍生物 Quinazoline derivatives
11/07/2007CN100347164C Benzofuryl derivatives and their use
11/07/2007CN100347158C Bicyclic compound
11/07/2007CN100347152C Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
11/07/2007CN100346824C 自体t-细胞疫苗材料和方法 Autologous t- vaccine MATERIALS AND METHODS Cell
11/07/2007CN100346823C Enamel matrix protein compositions for modulating immune response
11/07/2007CN100346808C Medicine for treating senile dementia and application of related Chinese medicinal composition
11/07/2007CN100346792C Benzothiazole derivatives as adenosine receptor ligands
11/07/2007CN100346790C Application of (+) North America coptisine
11/07/2007CN100346789C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury
11/07/2007CN100346779C Liquid pharmaceutical composition
11/07/2007CN100346776C Remedies
11/06/2007US7291738 A (2-methyl-3-pyridinyl)oxy)-3-pyridinyl)urea derivatives for treatment of a disease or disorder of the central nervous system, medical diagnosis
11/06/2007US7291734 N-(4,5,6,7-Tetrahydro-thiazolo[5,4-c]pyridin-2-yl)sulfonamides, e.g., 2-[2-(3,5-Bis-trifluoromethyl-benzenesulfonylamino)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]-4-trifluoromethyl-benzamide; steroid sulfatase inhibitors used to treat diseases including acne
11/06/2007US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/06/2007US7291731 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents
11/06/2007US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease
11/06/2007US7291641 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
11/06/2007US7291637 4,7-Methano--, ethano-, oxy- or thio- indazol-3-ones or benzisothiazol-3-ones in which the S is mono- or dioxygenated, e.g., 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one-1,1-dioxide; treatment of diseases such as cancer and immune disorders
11/06/2007US7291636 E.g., Methyl 2-[2-[2-(3,5-difluorophenyl)acetyl-amino]propanoylamino]-5-propylthiazole-4-carboxylate; beta -amyloid peptide inhibitors; used to treat senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy and/or cerebrovascular disorders
11/06/2007US7291633 nicotinic alpha 7 receptor and 5-HT3 or 5-HT6 receptor; control of cholinergic and dopaminergic neurotransmission; disorders of the central nervous system and serotonergic hyperactivity; psychiatric and neurodegenerativce disorders; antiemetics during chemotherapy
11/06/2007US7291630 Azaindoles as inhibitors of c-Jun N-terminal kinases
11/06/2007US7291629 Neurotrophin antagonist compositions
11/06/2007US7291627 E.g., 8-chloro-3,11-dimethyl-5,6-dihydroimidazo[5,1-a]- beta -carboline methane sulfonate; used for reducing alertness and/or for accelerating the onset of sleep
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/06/2007US7291622 Administering a 4-Amino-2-[1-(o-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinylcarbamate derivative, optionally mixed with an organic nitrate or NO donor or a cGMP inhibitor for treating sexual dysfunction
11/06/2007US7291613 Inhibitors of p38 kinase
11/06/2007US7291611 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain
11/06/2007US7291599 Such as amistatin and leuhistin; for control of inflammation; topical creams, gels, ointments
11/06/2007US7291454 Comprises antisense olignucleotides, ribozymes, DNA and guide sequences; animal models; genetic engineering; for use in drug screening
11/06/2007US7291451 Modulation of pericyte proliferation
11/06/2007US7291347 Solubility, permeability, and bioavailability; oral dosage
11/06/2007US7291344 Administering a botulinum toxin
11/06/2007US7291330 MD-1 inhibitors as immune suppressants
11/06/2007CA2427576C Benzodiazepine derivatives as gaba a receptor modulators
11/06/2007CA2388564C Caspase inhibitor
11/06/2007CA2353527C Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
11/06/2007CA2266556C Nmda (n-methyl-d-aspartate) antagonists
11/06/2007CA2263927C Heterocyclic thioesters and ketones
11/06/2007CA2241666C Tricyclic compounds, their production and use
11/06/2007CA2114251C Igf-1 to improve the neural condition
11/03/2007CA2587129A1 Methods and compositions for stem cell therapies
11/02/2007CA2587002A1 Stem cells derived from bone marrow for tissue regeneration
11/01/2007WO2007124394A1 Substituted biphenyl carboxylic acids and derivatives thereof
11/01/2007WO2007124351A1 Terphenyl derivatives for treatment of alzheimer' s disease
11/01/2007WO2007124318A1 Inhibitors of c-fms kinase
11/01/2007WO2007124136A1 Use of 4-amino-piperidines for treating sleep disorders
11/01/2007WO2007123953A2 Phosphodiesterase 4 inhibitors
11/01/2007WO2007123269A1 Azolecarboxamide derivative
11/01/2007WO2007123234A1 Antiepileptic action enhancer
11/01/2007WO2007123187A1 Pharmaceutical composition for conformational disease
11/01/2007WO2007123186A1 Pharmaceutical product
11/01/2007WO2007123153A1 Capsule for oral administration
11/01/2007WO2007122976A1 Therapeutic agent or development inhibitor of polyglutamine disease
11/01/2007WO2007122975A1 Hgf precursor protein mutant and activated form thereof
11/01/2007WO2007122815A1 Bivalent antibody directed against bir1
11/01/2007WO2007122634A2 Pyrimidinediones as tyrosine kinase inhibitors
11/01/2007WO2007122274A1 Acetylcholinesterase-inhibiting compounds for treating alzheimer's disease
11/01/2007WO2007122241A1 Compounds which potentiate ampa receptor and uses thereof in medicine